SMITHKLINE BEECHAM WILL MARKET GENERIC TAGAMET TO MANAGED CARE GROUPS; LEDERLE SHIPMENTS TO WHOLESALERS, RETAIL PHARMACIES SET TO BEGIN MAY 16
Executive Summary
SmithKline Beecham will manufacture a generic version of Tagamet (cimetidine) under the label of its Penn Labs subsidiary and market the product to hospitals and managed care organizations, the company said May 10. SB will manufacture generic cimetidine under the Tagamet NDA. The generic version will be yellow to distinguish it from the pale green color of the branded product, the company said.